Citations (175)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Benjamin J Ragen, Jordan Seidel, Christine Chollak, Robert H Pietrzak & Alexander Neumeister. (2015) Investigational drugs under development for the treatment of PTSD. Expert Opinion on Investigational Drugs 24:5, pages 659-672.
Read now
Read now
Giampaolo Perna, Koen Schruers, Alessandra Alciati & Daniela Caldirola. (2015) Novel investigational therapeutics for panic disorder. Expert Opinion on Investigational Drugs 24:4, pages 491-505.
Read now
Read now
Jacob Raber & Robert M Duvoisin. (2015) Novel metabotropic glutamate receptor 4 and glutamate receptor 8 therapeutics for the treatment of anxiety. Expert Opinion on Investigational Drugs 24:4, pages 519-528.
Read now
Read now
Giampaolo Perna, Giuseppe Guerriero & Daniela Caldirola. (2011) Emerging drugs for panic disorder. Expert Opinion on Emerging Drugs 16:4, pages 631-645.
Read now
Read now
Carlos Zarate, Rodrigo Machado-Vieira, Ioline Henter, Lobna Ibrahim, Nancy Diazgranados & Giacomo Salvadore. (2010) Glutamatergic Modulators: The Future of Treating Mood Disorders?. Harvard Review of Psychiatry 18:5, pages 293-303.
Read now
Read now
Dewleen G Baker, Caroline M Nievergelt & Victoria B Risbrough. (2009) Post-traumatic stress disorder: emerging concepts of pharmacotherapy. Expert Opinion on Emerging Drugs 14:2, pages 251-272.
Read now
Read now
Articles from other publishers (169)
Damian J. Woodward, Jackson G. Thorp, Wole Akosile, Jue-Sheng Ong, Eric R. Gamazon, Eske M. Derks & Zachary F. Gerring. (2023) Identification of drug repurposing candidates for the treatment of anxiety: A genetic approach. Psychiatry Research 326, pages 115343.
Crossref
Crossref
Xuyan Guan & Peng Cao. (2023) Brain Mechanisms Underlying Panic Attack and Panic Disorder. Neuroscience Bulletin.
Crossref
Crossref
Stephen W. White, Gwendolyn D. Squires, Sequioa J. Smith, Gwendolyn M. Wright, Kenneth J. Sufka, John M. Rimoldi & Rama S. Gadepalli. (2023) Anxiolytic-like effects of an mGluR 5 antagonist and a mGluR 2/3 agonist, and antidepressant-like effects of an mGluR 7 agonist in the chick social separation stress test, a dual-drug screening model of treatment-resistant depression. Pharmacology Biochemistry and Behavior 227-228, pages 173588.
Crossref
Crossref
Thian-Sze Wong, Guangzhi Li, Shiliang Li, Wei Gao, Geng Chen, Shiyi Gan, Manzhan Zhang, Honglin Li, Song Wu & Yang Du. (2023) G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Si Han Li, Khaled S. Abd-Elrahman & Stephen S.G. Ferguson. (2022) Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases. Pharmacology & Therapeutics 239, pages 108275.
Crossref
Crossref
Deborah J. Luessen & P. Jeffrey Conn. (2022) Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease. Pharmacological Reviews 74:3, pages 630-661.
Crossref
Crossref
Caroline S. Copeland, Stuart A. Neale, Eric S. Nisenbaum & Thomas E. Salt. (2021)
Group II metabotropic glutamate receptor (
mGlu
2
and
mGlu
3
) roles in thalamic processing
. British Journal of Pharmacology 179:8, pages 1607-1619.
Crossref
Crossref
Remy Verhaeghe, Vance Gao, Sara Morley-Fletcher, Hammou Bouwalerh, Gilles Van Camp, Francesca Cisani, Ferdinando Nicoletti & Stefania Maccari. (2021) Maternal stress programs a demasculinization of glutamatergic transmission in stress-related brain regions of aged rats. GeroScience 44:2, pages 1047-1069.
Crossref
Crossref
Tália Cássia Boff, Silvio José Batista Soares, Millena Daher Medeiros Lima & Zuleide Maria Ignácio. 2022. Glutamate and Neuropsychiatric Disorders. Glutamate and Neuropsychiatric Disorders
539
570
.
Shalini Dogra & P. Jeffrey Conn. (2021) Targeting metabotropic glutamate receptors for the treatment of depression and other stress-related disorders. Neuropharmacology 196, pages 108687.
Crossref
Crossref
Karen J. Gregory & Cyril Goudet. (2020) International Union of Basic and Clinical Pharmacology. CXI. Pharmacology, Signaling, and Physiology of Metabotropic Glutamate Receptors. Pharmacological Reviews 73:1, pages 521-569.
Crossref
Crossref
Christian Grillon & Monique Ernst. (2020) A way forward for anxiolytic drug development: Testing candidate anxiolytics with anxiety-potentiated startle in healthy humans. Neuroscience & Biobehavioral Reviews 119, pages 348-354.
Crossref
Crossref
A. Irem Sonmez, Ammar Almorsy, Laura B. Ramsey, Jeffrey R. Strawn & Paul E. Croarkin. (2020) Novel pharmacological treatments for generalized anxiety disorder: Pediatric considerations. Depression and Anxiety 37:8, pages 747-759.
Crossref
Crossref
Gerard J. Marek & Allyson A. Salek. (2020) Extending the Specificity of DRL 72-s Behavior for Screening Antidepressant-Like Effects of Glutamatergic Clinically Validated Anxiolytic or Antidepressant Drugs in Rats. Journal of Pharmacology and Experimental Therapeutics 374:1, pages 200-210.
Crossref
Crossref
Cong Zheng, Yan Xu, Guiqin Chen, Yang Tan, Weiqi Zeng, Ji Wang, Chi Cheng, Xiaoman Yang, Shuke Nie, Zhentao Zhang & Xuebing Cao. (2020) Distinct anti-dyskinetic effects of amantadine and group II metabotropic glutamate receptor agonist LY354740 in a rodent model: An electrophysiological perspective. Neurobiology of Disease 139, pages 104807.
Crossref
Crossref
Hanna I. Severina, Victoriya A. Georgiyants, Sergiy M. Kovalenko, Natalia V. Avdeeva, Artem I. Yarcev & Svetlana N. Prohoda. (2020) Molecular docking studies of N-substituted 4-methoxy-6-oxo-1-aryl-pyridazine-3-carboxamide derivatives as potential modulators of glutamate receptors. Research Results in Pharmacology 6:1, pages 69-82.
Crossref
Crossref
Yang Tan, Yan Xu, Chi Cheng, Cong Zheng, Weiqi Zeng, Ji Wang, Xiaoqian Zhang, Xiaoman Yang, Jialing Wang, Xiaomei Yang, Shuke Nie & Xuebing Cao. (2020) LY354740 Reduces Extracellular Glutamate Concentration, Inhibits Phosphorylation of Fyn/NMDARs, and Expression of PLK2/pS129 α-Synuclein in Mice Treated With Acute or Sub-Acute MPTP. Frontiers in Pharmacology 11.
Crossref
Crossref
A. I. Molosh, E. T. Dustrude, J. L. Lukkes, S. D. Fitz, I. F. Caliman, A. R. R. Abreu, A. D. Dietrich, W. A. Truitt, L. Ver Donck, M. Ceusters, J. M. Kent, P. L. Johnson & A . Shekhar. (2018) Panic results in unique molecular and network changes in the amygdala that facilitate fear responses. Molecular Psychiatry 25:2, pages 442-460.
Crossref
Crossref
Christiana K. Miller, Amanda A. Krentzel, Heather B. Patisaul & John Meitzen. (2020) Metabotropic glutamate receptor subtype 5 (mGlu5) is necessary for estradiol mitigation of light-induced anxiety behavior in female rats. Physiology & Behavior 214, pages 112770.
Crossref
Crossref
Mohamed S. Zulfarina, Syed-Badrul Syarifah-Noratiqah, Shuid A. Nazrun, Razinah Sharif & Isa Naina-Mohamed. (2019) Pharmacological Therapy in Panic Disorder: Current Guidelines and Novel Drugs Discovery for Treatment-resistant Patient. Clinical Psychopharmacology and Neuroscience 17:2, pages 145-154.
Crossref
Crossref
Seon-Cheol Park & Yong-Ku Kim. (2019) A Novel Bio-Psychosocial-Behavioral Treatment Model of Panic Disorder. Psychiatry Investigation 16:1, pages 4-15.
Crossref
Crossref
Mark J. Benvenga, Stephen F. Chaney, Melvyn Baez, Thomas C. Britton, William J. Hornback, James A. Monn & Gerard J. Marek. (2018) Metabotropic Glutamate2 Receptors Play a Key Role in Modulating Head Twitches Induced by a Serotonergic Hallucinogen in Mice. Frontiers in Pharmacology 9.
Crossref
Crossref
Francesco Ferraguti. (2018) Metabotropic glutamate receptors as targets for novel anxiolytics. Current Opinion in Pharmacology 38, pages 37-42.
Crossref
Crossref
Kathy Sengmany & Karen J. Gregory. 2018. Biochemical Approaches for Glutamatergic Neurotransmission. Biochemical Approaches for Glutamatergic Neurotransmission
227
261
.
C.S. Copeland, T.M. Wall, R.E. Sims, S.A. Neale, E. Nisenbaum, H.R. Parri & T.E. Salt. (2017) Astrocytes modulate thalamic sensory processing via mGlu2 receptor activation. Neuropharmacology 121, pages 100-110.
Crossref
Crossref
Shigeyuki Chaki. (2017) mGlu2/3 Receptor Antagonists as Novel Antidepressants. Trends in Pharmacological Sciences 38:6, pages 569-580.
Crossref
Crossref
Michael P Johnson, Mark A Muhlhauser, Eric S Nisenbaum, Rosa M A Simmons, Beth M Forster, Kelly L Knopp, Lijuan Yang, Denise Morrow, Dominic L Li, Jeffrey D Kennedy, Steven Swanson & James A Monn. (2017) Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2/3 receptor agonist LY2934747, in rodent pain models. British Journal of Pharmacology 174:9, pages 822-835.
Crossref
Crossref
J.M. Witkin, S.N. Mitchell, K.A. Wafford, G. Carter, G. Gilmour, J. Li, B.J. Eastwood, C. Overshiner, X. Li, L. Rorick-Kehn, K. Rasmussen, W.H. Anderson, A. Nikolayev, V.V. Tolstikov, M.-S. Kuo, J.T. Catlow, R. Li, S.C. Smith, C.H. Mitch, P.L. Ornstein, S. Swanson & J.A. Monn. (2017)
Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive
N
-Methyl-d-Aspartate Receptor Antagonist in Rodents: Evidence Supporting the Use of mGlu2/3 Antagonists, for the Treatment of Depression.
. Journal of Pharmacology and Experimental Therapeutics 361:1, pages 68-86.
Crossref
Crossref
Jeffrey M. Witkin, Paul L. Ornstein, Charles H. Mitch, Renhua Li, Stephon C. Smith, Beverly A. Heinz, Xu-Shan Wang, Chuanxi Xiang, Joan H. Carter, Wesley H. Anderson, Xia Li, Lisa M. Broad, Francesca Pasqui, Stephen M. Fitzjohn, Helen E. Sanger, Jodi L. Smith, John Catlow, Steven Swanson & James A. Monn. (2017) In vitro pharmacological and rat pharmacokinetic characterization of LY3020371, a potent and selective mGlu 2/3 receptor antagonist. Neuropharmacology 115, pages 100-114.
Crossref
Crossref
A. A. Trabanco, J. M. Cid & G. Tresadern. 2016. Allosterism in Drug Discovery. Allosterism in Drug Discovery
156
174
.
Jose María Cid, Gary Tresadern, Juan Antonio Vega, Ana Isabel de Lucas, Alcira del Cerro, Encarnación Matesanz, María Lourdes Linares, Aránzazu García, Laura Iturrino, Laura Pérez-Benito, Gregor J. Macdonald, Daniel Oehlrich, Hilde Lavreysen, Luc Peeters, Marc Ceusters, Abdellah Ahnaou, Wilhelmus Drinkenburg, Claire Mackie, Marijke Somers & Andrés A. Trabanco. (2016)
Discovery of 8-Trifluoromethyl-3-cyclopropylmethyl-7-[(4-(2,4-difluorophenyl)-1-piperazinyl)methyl]-1,2,4-triazolo[4,3-
a
]pyridine (JNJ-46356479), a Selective and Orally Bioavailable mGlu2 Receptor Positive Allosteric Modulator (PAM)
. Journal of Medicinal Chemistry 59:18, pages 8495-8507.
Crossref
Crossref
Anushree N. Karkhanis, Thomas J.R. Beveridge, Bruce E. Blough, Sara R. Jones & Mark J. Ferris. (2016) The individual and combined effects of phenmetrazine and mgluR2/3 agonist LY379268 on the motivation to self-administer cocaine. Drug and Alcohol Dependence 166, pages 51-60.
Crossref
Crossref
Craig W. Lindsley, Kyle A. Emmitte, Corey R. Hopkins, Thomas M. Bridges, Karen J. Gregory, Colleen M. Niswender & P. Jeffrey Conn. (2016) Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors. Chemical Reviews 116:11, pages 6707-6741.
Crossref
Crossref
A. Ahnaou, P. de Boer, H. Lavreysen, H. Huysmans, V. Sinha, L. Raeymaekers, T. Van De Casteele, J.M. Cid, L. Van Nueten, G.J. Macdonald, J.A. Kemp & W.H.I.M. Drinkenburg. (2016) Translational neurophysiological markers for activity of the metabotropic glutamate receptor (mGluR2) modulator JNJ-40411813: Sleep EEG correlates in rodents and healthy men. Neuropharmacology 103, pages 290-305.
Crossref
Crossref
K. J. Gregory & P. J. Conn. (2015) Molecular Insights into Metabotropic Glutamate Receptor Allosteric Modulation. Molecular Pharmacology 88:1, pages 188-202.
Crossref
Crossref
Changjiu Zhao & Stephen C. Gammie. (2015) Metabotropic Glutamate Receptor 3 Is Downregulated and Its Expression Is Shifted From Neurons to Astrocytes in the Mouse Lateral Septum During the Postpartum Period. Journal of Histochemistry & Cytochemistry 63:6, pages 417-426.
Crossref
Crossref
C.S. Copeland, S.A. Neale & T.E. Salt. (2015) Neuronal activity patterns in the mediodorsal thalamus and related cognitive circuits are modulated by metabotropic glutamate receptors. Neuropharmacology 92, pages 16-24.
Crossref
Crossref
Hiba Salih, Ion Anghelescu, Iva Kezic, Vikash Sinha, Eef Hoeben, Luc Van Nueten, Heidi De Smedt & Peter De Boer. (2015) Pharmacokinetic and pharmacodynamic characterisation of JNJ-40411813, a positive allosteric modulator of mGluR2, in two randomised, double-blind phase-I studies. Journal of Psychopharmacology 29:4, pages 414-425.
Crossref
Crossref
Bianca De Filippis, Louisa Lyon, Amy Taylor, Tracy Lane, Philip W.J. Burnet, Paul J. Harrison & David M. Bannerman. (2015) The role of group II metabotropic glutamate receptors in cognition and anxiety: Comparative studies in GRM2−/−, GRM3−/− and GRM2/3−/− knockout mice. Neuropharmacology 89, pages 19-32.
Crossref
Crossref
Hilde Lavreysen, Abdellah Ahnaou, Wilhelmus Drinkenburg, Xavier Langlois, Claire Mackie, Stefan Pype, Robert Lütjens, Emmanuel Le Poul, Andrés A. Trabanco & José María Cid Nuñez. (2015) Pharmacological and pharmacokinetic properties of JNJ-40411813, a positive allosteric modulator of the mGlu2 receptor. Pharmacology Research & Perspectives 3:1, pages e00096.
Crossref
Crossref
Tetsuaki Hiyoshi, Toshiyuki Marumo, Hirohiko Hikichi, Yasumitsu Tomishima, Hiroki Urabe, Tomoko Tamita, Izumi Iida, Akito Yasuhara, Jun-ichi Karasawa & Shigeyuki Chaki. (2014) Neurophysiologic and Antipsychotic Profiles of TASP0433864, a Novel Positive Allosteric Modulator of Metabotropic Glutamate 2 Receptor. Journal of Pharmacology and Experimental Therapeutics 351:3, pages 642-653.
Crossref
Crossref
Michael Davis & David L. Walker. (2013) Role of bed nucleus of the stria terminalis and amygdala AMPA receptors in the development and expression of context conditioning and sensitization of startle by prior shock. Brain Structure and Function 219:6, pages 1969-1982.
Crossref
Crossref
Philip L. Johnson, Lauren M. Federici & Anantha Shekhar. (2014) Etiology, triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacks. Neuroscience & Biobehavioral Reviews 46, pages 429-454.
Crossref
Crossref
Shen Yin & Colleen M. Niswender. (2014) Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications. Cellular Signalling 26:10, pages 2284-2297.
Crossref
Crossref
Gary Tresadern, José-Maria Cid & Andrés A. Trabanco. (2014) QSAR design of triazolopyridine mGlu2 receptor positive allosteric modulators. Journal of Molecular Graphics and Modelling 53, pages 82-91.
Crossref
Crossref
José María Cid, Gary Tresadern, Guillaume Duvey, Robert Lütjens, Terry Finn, Jean-Philippe Rocher, Sonia Poli, Juan Antonio Vega, Ana Isabel de Lucas, Encarnación Matesanz, María Lourdes Linares, José Ignacio Andrés, Jesús Alcazar, José Manuel Alonso, Gregor J. Macdonald, Daniel Oehlrich, Hilde Lavreysen, Abdelah Ahnaou, Wilhelmus Drinkenburg, Claire Mackie, Stefan Pype, David Gallacher & Andrés A. Trabanco. (2014)
Discovery of 1-Butyl-3-chloro-4-(4-phenyl-1-piperidinyl)-(1
H
)-pyridone (JNJ-40411813): A Novel Positive Allosteric Modulator of the Metabotropic Glutamate 2 Receptor
. Journal of Medicinal Chemistry 57:15, pages 6495-6512.
Crossref
Crossref
Clare Finlay & Susan Duty. (2014) Therapeutic potential of targeting glutamate receptors in Parkinson’s disease. Journal of Neural Transmission 121:8, pages 861-880.
Crossref
Crossref
Hilary Highfield Nickols & P. Jeffrey Conn. (2014) Development of allosteric modulators of GPCRs for treatment of CNS disorders. Neurobiology of Disease 61, pages 55-71.
Crossref
Crossref
J. Haller, M. Aliczki & K. Gyimesine Pelczer. (2013) Classical and novel approaches to the preclinical testing of anxiolytics: A critical evaluation. Neuroscience & Biobehavioral Reviews 37:10, pages 2318-2330.
Crossref
Crossref
H. Lavreysen, X. Langlois, A. Ahnaou, W. Drinkenburg, P. te Riele, I. Biesmans, I. Van der Linden, L. Peeters, A. Megens, C. Wintmolders, J. M. Cid, A. A. Trabanco, J. I. Andres, F. M. Dautzenberg, R. Lutjens, G. Macdonald & J. R. Atack. (2013) Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782. Journal of Pharmacology and Experimental Therapeutics 346:3, pages 514-527.
Crossref
Crossref
Jia Cheng, Wenhua Liu, Lara J. Duffney & Zhen Yan. (2013) SNARE proteins are essential in the potentiation of NMDA receptors by group II metabotropic glutamate receptors. The Journal of Physiology 591:16, pages 3935-3947.
Crossref
Crossref
James A. Monn, Matthew J. Valli, Steven M. Massey, Junliang Hao, Matthew R. Reinhard, Mark G. Bures, Beverly A. Heinz, Xushan Wang, Joan H. Carter, Brian G. Getman, Gregory A. Stephenson, Marc Herin, John T. Catlow, Steven Swanson, Bryan G. Johnson, David L. McKinzie & Steven S. Henry. (2013) Synthesis and Pharmacological Characterization of 4-Substituted-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylates: Identification of New Potent and Selective Metabotropic Glutamate 2/3 Receptor Agonists. Journal of Medicinal Chemistry 56:11, pages 4442-4455.
Crossref
Crossref
Michihiko Iijima, Hiroyuki Koike & Shigeyuki Chaki. (2013) Effect of an mGlu2/3 receptor antagonist on depressive behavior induced by withdrawal from chronic treatment with methamphetamine. Behavioural Brain Research 246, pages 24-28.
Crossref
Crossref
Helen Sanger, Lydia Hanna, Ellen M. Colvin, Olivera Grubisha, Daniel Ursu, Beverly A. Heinz, Jeremy D. Findlay, Richard G. Vivier, Emanuele Sher, David Lodge, James A. Monn & Lisa M. Broad. (2013) Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR. Neuropharmacology 66, pages 264-273.
Crossref
Crossref
Daniela Durand, Lila Carniglia, Carla Caruso & Mercedes Lasaga. (2013) mGlu3 receptor and astrocytes: Partners in neuroprotection. Neuropharmacology 66, pages 1-11.
Crossref
Crossref
Z.A. Hughes, S.J. Neal, D.L. Smith, S.J. Sukoff Rizzo, C.M. Pulicicchio, S. Lotarski, S. Lu, J.M. Dwyer, J. Brennan, M. Olsen, C.N. Bender, E. Kouranova, T.H. Andree, J.E. Harrison, G.T. Whiteside, D. Springer, S.V. O'Neil, S.K. Leonard, L.E. Schechter, J. Dunlop, S. Rosenzweig-Lipson & R.H. Ring. (2013) Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression. Neuropharmacology 66, pages 202-214.
Crossref
Crossref
Rebecca A. Wright, Bryan G. Johnson, Ce Zhang, Craig Salhoff, Ann E. Kingston, David O. Calligaro, James A. Monn, Darryle D. Schoepp & Gerard J. Marek. (2013) CNS distribution of metabotropic glutamate 2 and 3 receptors: Transgenic mice and [3H]LY459477 autoradiography. Neuropharmacology 66, pages 89-98.
Crossref
Crossref
Philip L Johnson, Stephanie D Fitz, Eric A Engleman, Kjell A Svensson, Jeffrey M Schkeryantz & Anantha Shekhar. (2012) Group II metabotropic glutamate receptor type 2 allosteric potentiators prevent sodium lactate-induced panic-like response in panic-vulnerable rats. Journal of Psychopharmacology 27:2, pages 152-161.
Crossref
Crossref
David Camfield. 2013. Advances in Natural Medicines, Nutraceuticals and Neurocognition. Advances in Natural Medicines, Nutraceuticals and Neurocognition
29
42
.
Fabrizio Gasparini, Thérèse Di Paolo & Baltazar Gomez-Mancilla. (2013) Metabotropic Glutamate Receptors for Parkinson's Disease Therapy. Parkinson's Disease 2013, pages 1-11.
Crossref
Crossref
Karen J. Gregory, Meredith J. Noetzel & Colleen M. Niswender. 2013. Oligomerization and Allosteric Modulation in G-Protein Coupled Receptors. Oligomerization and Allosteric Modulation in G-Protein Coupled Receptors
61
121
.
Philip L. Johnson & Anantha Shekhar. (2012) An animal model of panic vulnerability with chronic disinhibition of the dorsomedial/perifornical hypothalamus. Physiology & Behavior 107:5, pages 686-698.
Crossref
Crossref
Erin R. Hascup, Kevin N. Hascup, Francois Pomerleau, Peter Huettl, Eva Hajos-Korcsok, Jan Kehr & Greg A. Gerhardt. (2012) An allosteric modulator of metabotropic glutamate receptors (mGluR2), (+)-TFMPIP, inhibits restraint stress-induced phasic glutamate release in rat prefrontal cortex. Journal of Neurochemistry 122:3, pages 619-627.
Crossref
Crossref
Ji-Quan Wang, Zhaoda Zhang, Darshini Kuruppu & Anna-Liisa Brownell. (2012) Radiosynthesis of PET radiotracer as a prodrug for imaging group II metabotropic glutamate receptors in vivo. Bioorganic & Medicinal Chemistry Letters 22:5, pages 1958-1962.
Crossref
Crossref
C. S. Copeland, S. A. Neale & T. E. Salt. (2012) Positive allosteric modulation reveals a specific role for mGlu2 receptors in sensory processing in the thalamus. The Journal of Physiology 590:4, pages 937-951.
Crossref
Crossref
Rodrigo Machado-Vieira, Lobna Ibrahim, Ioline D. Henter & Carlos A. ZarateJr.Jr.. (2012) Novel glutamatergic agents for major depressive disorder and bipolar disorder. Pharmacology Biochemistry and Behavior 100:4, pages 678-687.
Crossref
Crossref
Brian H. Harvey & Mohammed Shahid. (2012) Metabotropic and ionotropic glutamate receptors as neurobiological targets in anxiety and stress-related disorders: Focus on pharmacology and preclinical translational models. Pharmacology Biochemistry and Behavior 100:4, pages 775-800.
Crossref
Crossref
Carlos Riaza Bermudo-Soriano, M. Mercedes Perez-Rodriguez, Concepcion Vaquero-Lorenzo & Enrique Baca-Garcia. (2012) New perspectives in glutamate and anxiety. Pharmacology Biochemistry and Behavior 100:4, pages 752-774.
Crossref
Crossref
Chester J. Siok, Shawn M. Cogan, Lauren B. Shifflett, Angela C. Doran, Bernat Kocsis & Mihály Hajós. (2012) Comparative analysis of the neurophysiological profile of group II metabotropic glutamate receptor activators and diazepam: Effects on hippocampal and cortical EEG patterns in rats. Neuropharmacology 62:1, pages 226-236.
Crossref
Crossref
E. J. Herman, M. Bubser, P. J. Conn & C. K. Jones. 2012. Novel Antischizophrenia Treatments. Novel Antischizophrenia Treatments
297
365
.
Daniel C. JavittDarryle SchoeppPeter W. KalivasNora D. VolkowCarlos ZarateKalpana MerchantMark F. BearDaniel UmbrichtMihaly HajosWilliam Z. PotterChi-Ming Lee. (2011) Translating Glutamate: From Pathophysiology to Treatment. Science Translational Medicine 3:102.
Crossref
Crossref
Meng-Qi Zhang, Xiao-Le Zhang, Yan Li, Wen-Jia Fan, Yong-Hua Wang, Ming Hao, Shu-Wei Zhang & Chun-Zhi Ai. (2011) Investigation on Quantitative Structure Activity Relationships and Pharmacophore Modeling of a Series of mGluR2 Antagonists. International Journal of Molecular Sciences 12:9, pages 5999-6023.
Crossref
Crossref
Cecilio Lopez-Munoz & Francisco AlamoRodrigo Machado-Vieira & Carlos ZarateJrJr. 2011. Neurobiology of Depression. Neurobiology of Depression
185
202
.
Sarah M. Clinton, John D. H. Stead, Sue Miller, Stanley J. Watson & Huda Akil. (2011) Developmental underpinnings of differences in rodent novelty-seeking and emotional reactivity. European Journal of Neuroscience 34:6, pages 994-1005.
Crossref
Crossref
Douglas J. Sheffler, Anthony B. Pinkerton, Russell Dahl, Athina Markou & Nicholas D. P. Cosford. (2011) Recent Progress in the Synthesis and Characterization of Group II Metabotropic Glutamate Receptor Allosteric Modulators. ACS Chemical Neuroscience 2:8, pages 382-393.
Crossref
Crossref
Jorge E. Quintero, François Pomerleau, Peter Huettl, Kirk W. Johnson, James Offord & Greg A. Gerhardt. (2011) Methodology for rapid measures of glutamate release in rat brain slices using ceramic-based microelectrode arrays: Basic characterization and drug pharmacology. Brain Research 1401, pages 1-9.
Crossref
Crossref
Anne H. Borkowski, Dylan C. Barnes, Derek R. Blanchette, F. Xavier Castellanos, Donald F. Klein & Donald A. Wilson. (2011) Interaction between delta opioid receptors and benzodiazepines in CO2-induced respiratory responses in mice. Brain Research 1396, pages 54-59.
Crossref
Crossref
Laura Ceolin, Sriharsha Kantamneni, Gareth R. I. Barker, Lydia Hanna, Laura Murray, E. Clea Warburton, Emma S. J. Robinson, James A. Monn, Stephen M. Fitzjohn, Graham L. Collingridge, Zuner A. Bortolotto & David Lodge. (2011) Study of Novel Selective mGlu2 Agonist in the Temporo-Ammonic Input to CA1 Neurons Reveals Reduced mGlu2 Receptor Expression in a Wistar Substrain with an Anxiety-Like Phenotype. The Journal of Neuroscience 31:18, pages 6721-6731.
Crossref
Crossref
Gerard J. Marek. 2011. Translational Medicine and Drug Discovery. Translational Medicine and Drug Discovery
168
179
.
Lisa M. Del Valle-Mojica, José M. Cordero-Hernández, Giselle González-Medina, Igmeris Ramos-Vélez, Nairimer Berríos-Cartagena, Bianca A. Torres-Hernández & José G. Ortíz. (2011)
Aqueous and Ethanolic
Valeriana officinalis
Extracts Change the Binding of Ligands to Glutamate Receptors
. Evidence-Based Complementary and Alternative Medicine 2011, pages 1-7.
Crossref
Crossref
Matthew J. Fell, Jeffrey M. Witkin, Julie F. Falcone, Jason S. Katner, Kenneth W. Perry, John Hart, Linda Rorick-Kehn, Carl D. Overshiner, Kurt Rasmussen, Stephen F. Chaney, Mark J. Benvenga, Xia Li, Deanna L. Marlow, Linda K. Thompson, Susan K. Luecke, Keith A. Wafford, Wesley F. Seidel, Dale M. Edgar, Anne T. Quets, Christian C. Felder, XuShan Wang, Beverly A. Heinz, Alexander Nikolayev, Ming-Shang Kuo, Daniel Mayhugh, Albert Khilevich, Deyi Zhang, Philip J. Ebert, James A. Eckstein, Bradley L. Ackermann, Steven P. Swanson, John T. Catlow, Robert A. Dean, Kimberley Jackson, Sitra Tauscher-Wisniewski, Gerard J. Marek, Jeffrey M. Schkeryantz & Kjell A. Svensson. (2011)
N
-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1
H
-imidazole-4-carboxamide (THIIC), a Novel Metabotropic Glutamate 2 Potentiator with Potential Anxiolytic/Antidepressant Properties: In Vivo Profiling Suggests a Link between Behavioral and Central Nervous System Neurochemical Changes
. Journal of Pharmacology and Experimental Therapeutics 336:1, pages 165-177.
Crossref
Crossref
Andrés A. Trabanco, Guillaume Duvey, José María Cid, Gregor J. Macdonald, Philippe Cluzeau, Vanthea Nhem, Rocco Furnari, Nadia Behaj, Géraldine Poulain, Terry Finn, Sonia Poli, Hilde Lavreysen, Alexandre Raux, Yves Thollon, Nicolas Poirier, David D'Addona, José Ignacio Andrés, Robert Lutjens, Emmanuel Le Poul, Hassan Imogai & Jean-Philippe Rocher. (2011) New positive allosteric modulators of the metabotropic glutamate receptor 2 (mGluR2). Identification and synthesis of N-propyl-5-substituted isoquinolones. Med. Chem. Commun. 2:2, pages 132-139.
Crossref
Crossref
Karen J. Gregory, Elizabeth N. Dong, Jens Meiler & P. Jeffrey Conn. (2011) Allosteric modulation of metabotropic glutamate receptors: Structural insights and therapeutic potential. Neuropharmacology 60:1, pages 66-81.
Crossref
Crossref
Jose María Cid, Guillaume Duvey, Philippe Cluzeau, Vanthea Nhem, Karim Macary, Alexandre Raux, Nicolas Poirier, Jessica Muller, Christelle Boléa, Terry Finn, Sonia Poli, Mark Epping-Jordan, Emilie Chamelot, Francis Derouet, Francoise Girard, Gregor J. Macdonald, Juan Antonio Vega, Ana Isabel de Lucas, Encarnación Matesanz, Hilde Lavreysen, María Lourdes Linares, Daniel Oehlrich, Julen Oyarzábal, Gary Tresadern, Andrés A. Trabanco, Jose Ignacio Andrés, Emmanuel Le Poul, Hassan Imogai, Robert Lutjens & Jean-Philippe Rocher. (2010) Discovery of 1,5-Disubstituted Pyridones: A New Class of Positive Allosteric Modulators of the Metabotropic Glutamate 2 Receptor. ACS Chemical Neuroscience 1:12, pages 788-795.
Crossref
Crossref
Grayson Richards, Jürg Messer, Richard L.M. Faull, Heinz Stadler, Jürgen Wichmann, Philipp Huguenin, Bernd Bohrmann & Vincent Mutel. (2010) Altered distribution of mGlu2 receptors in β-amyloid-affected brain regions of Alzheimer cases and aged PS2APP mice. Brain Research 1363, pages 180-190.
Crossref
Crossref
Richard M. O'Connor & John F. Cryan. 2012. G Protein-Coupled Receptors. G Protein-Coupled Receptors
321
379
.
John H. Krystal, Sanjay J. Mathew, D. Cyril DʼSouza, Amir Garakani, Handan Gunduz-Bruce & Dennis S. Charney. (2010) Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists. CNS Drugs 24:8, pages 669-693.
Crossref
Crossref
Gerard J. Marek. (2010) Metabotropic glutamate2/3 (mGlu2/3) receptors, schizophrenia and cognition. European Journal of Pharmacology 639:1-3, pages 81-90.
Crossref
Crossref
Shigeyuki Chaki. (2010) Group II metabotropic glutamate receptor agonists as a potential drug for schizophrenia. European Journal of Pharmacology 639:1-3, pages 59-66.
Crossref
Crossref
Suat Ying Tan Cherlyn, Puay San Woon, Jian Jun Liu, Wei Yi Ong, Guo Chuan Tsai & Kang Sim. (2010) Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: A decade of advance. Neuroscience & Biobehavioral Reviews 34:6, pages 958-977.
Crossref
Crossref
Colleen M. NiswenderP. Jeffrey Conn. (2010) Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease. Annual Review of Pharmacology and Toxicology 50:1, pages 295-322.
Crossref
Crossref
Will Spooren, Anne Lesage, Hilde Lavreysen, Fabrizio Gasparini & Thomas Steckler. 2010. Behavioral Neurobiology of Anxiety and Its Treatment. Behavioral Neurobiology of Anxiety and Its Treatment
391
413
.
Rodrigo Machado-Vieira, Husseini K. Manji & Carlos A. Zarate. (2009) The Role of the Tripartite Glutamatergic Synapse in the Pathophysiology and Therapeutics of Mood Disorders. The Neuroscientist 15:5, pages 525-539.
Crossref
Crossref
K. Stachowicz, A. Kłodzińska, A. Palucha-Poniewiera, S. Schann, P. Neuville & A. Pilc. (2009) The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems. Neuropharmacology 57:3, pages 227-234.
Crossref
Crossref
K. Mitsukawa, X. Lu & T. Bartfai. (2009) Bidirectional regulation of stress responses by galanin in mice: Involvement of galanin receptor subtype 1. Neuroscience 160:4, pages 837-846.
Crossref
Crossref
Jamie Peters, Peter W. Kalivas & Gregory J. Quirk. (2009) Extinction circuits for fear and addiction overlap in prefrontal cortex. Learning & Memory 16:5, pages 279-288.
Crossref
Crossref
P. Jeffrey Conn, Arthur Christopoulos & Craig W. Lindsley. (2009) Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Nature Reviews Drug Discovery 8:1, pages 41-54.
Crossref
Crossref
Joanna M. Wierońska & Andrzej Pilc. (2009) Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs. Neurochemistry International 55:1-3, pages 85-97.
Crossref
Crossref
Abdellah Ahnaou, Frank M. Dautzenberg, Helena Geys, Hassan Imogai, Antoine Gibelin, Dieder Moechars, Thomas Steckler & Wilhelmus H.I.M. Drinkenburg. (2009) Modulation of group II metabotropic glutamate receptor (mGlu2) elicits common changes in rat and mice sleep–wake architecture. European Journal of Pharmacology 603:1-3, pages 62-72.
Crossref
Crossref
C. Durant, D. Christmas & D. Nutt. 2010. Behavioral Neurobiology of Anxiety and Its Treatment. Behavioral Neurobiology of Anxiety and Its Treatment
303
330
.
Anton Y. Bespalov, Marcel M. van Gaalen, Irina A. Sukhotina, Karsten Wicke, Mario Mezler, Hans Schoemaker & Gerhard Gross. (2008) Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression. European Journal of Pharmacology 592:1-3, pages 96-102.
Crossref
Crossref
Eduardo Dunayevich, Janelle Erickson, Louise Levine, Ronald Landbloom, Darryle D Schoepp & Gary D Tollefson. (2007) Efficacy and Tolerability of an mGlu2/3 Agonist in the Treatment of Generalized Anxiety Disorder. Neuropsychopharmacology 33:7, pages 1603-1610.
Crossref
Crossref
Mark H. Pollack, Michael W. Otto, Peter P. Roy-Byrne, Jeremy D. Coplan, Barbara O. Rothbaum, Naomi M. Simon & Jack M. Gorman. (2008) Novel treatment approaches for refractory anxiety disorders. Depression and Anxiety 25:6, pages 467-476.
Crossref
Crossref
Guibao Gu, Daniel S. Lorrain, Hongbing Wei, Rebecca L. Cole, Xin Zhang, Lorrie P. Daggett, Herve J. Schaffhauser, Linda J. Bristow & Sandra M. Lechner. (2008) Distribution of metabotropic glutamate 2 and 3 receptors in the rat forebrain: Implication in emotional responses and central disinhibition. Brain Research 1197, pages 47-62.
Crossref
Crossref
Andrzej Pilc, Shigeyuki Chaki, Gabriel Nowak & Jeffrey M. Witkin. (2008) Mood disorders: Regulation by metabotropic glutamate receptors. Biochemical Pharmacology 75:5, pages 997-1006.
Crossref
Crossref
Matthias E Liechti & Athina Markou. (2008) Role of the Glutamatergic System in Nicotine Dependence. CNS Drugs 22:9, pages 705-724.
Crossref
Crossref
Ashley E. Brady & P. Jeffrey Conn. 2008. The Glutamate Receptors. The Glutamate Receptors
529
564
.
Michael P. Johnson & Darryle D. Schoepp. 2008. The Glutamate Receptors. The Glutamate Receptors
465
488
.
Everett J. Perkins & Trent Abraham. (2007)
Pharmacokinetics, Metabolism, and Excretion of the Intestinal Peptide Transporter 1 (SLC15A1)-Targeted Prodrug (1
S
,2
S
,5
R
,6
S
)-2-[(2′
S
)-(2-Amino)propionyl]aminobicyclo[3.1.0.]hexen-2,6-dicarboxylic acid (LY544344) in Rats and Dogs: Assessment of First-Pass Bioactivation and Dose Linearity
. Drug Metabolism and Disposition 35:10, pages 1903-1909.
Crossref
Crossref
Laurent B. Nicolas, Steffen Klein & Eric P. Prinssen. (2007) Defensive-like behaviors induced by ultrasound: further pharmacological characterization in Lister-hooded rats. Psychopharmacology 194:2, pages 243-252.
Crossref
Crossref
Daniela Melchiorri, Irene Cappuccio, Cinzia Ciceroni, Paola Spinsanti, Paola Mosillo, Iran Sarichelou, Patrizio Sale & Ferdinando Nicoletti. (2007) Metabotropic glutamate receptors in stem/progenitor cells. Neuropharmacology 53:4, pages 473-480.
Crossref
Crossref
Jonathan M. Amiel & Sanjay J. Mathew. (2007) Glutamate and anxiety disorders. Current Psychiatry Reports 9:4, pages 278-283.
Crossref
Crossref
Agnieszka Palucha & Andrzej Pilc. (2007) Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs. Pharmacology & Therapeutics 115:1, pages 116-147.
Crossref
Crossref
Linda M. Rorick-Kehn, Bryan G. Johnson, Karen M. Knitowski, Craig R. Salhoff, Jeffrey M. Witkin, Kenneth W. Perry, Kelly I. Griffey, Joseph P. Tizzano, James A. Monn, David L. McKinzie & Darryle D. Schoepp. (2007) In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders. Psychopharmacology 193:1, pages 121-136.
Crossref
Crossref
Linda M. Rorick-Kehn, Bryan G. Johnson, Jennifer L. Burkey, Rebecca A. Wright, David O. Calligaro, Gerard J. Marek, Eric S. Nisenbaum, John T. Catlow, Ann E. Kingston, Deborah D. Giera, Marc F. Herin, James A. Monn, David L. McKinzie & Darryle D. Schoepp. (2007)
Pharmacological and Pharmacokinetic Properties of a Structurally Novel, Potent, and Selective Metabotropic Glutamate 2/3 Receptor Agonist: In Vitro Characterization of Agonist (–)-(1
R
,4
S
,5
S
,6
S
)-4-Amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic Acid (LY404039)
. Journal of Pharmacology and Experimental Therapeutics 321:1, pages 308-317.
Crossref
Crossref
Enrique Portillo & José M. Vela. 2007. Antidepressants, Antipsychotics, Anxiolytics. Antidepressants, Antipsychotics, Anxiolytics
923
949
.
James A. Monn, Michael P. Johnson & Darryle D. Schoepp. 2007. Handbook of Contemporary Neuropharmacology. Handbook of Contemporary Neuropharmacology.
T. Blackburn & J. Wasley. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
45
83
.
Michihiko Iijima, Toshiharu Shimazaki, Akie Ito & Shigeyuki Chaki. (2006) Effects of metabotropic glutamate 2/3 receptor antagonists in the stress-induced hyperthermia test in singly housed mice. Psychopharmacology 190:2, pages 233-239.
Crossref
Crossref
Anni-Maija Linden & Darryle D. Schoepp. (2006) Metabotropic glutamate receptor targets for neuropsychiatric disorders. Drug Discovery Today: Therapeutic Strategies 3:4, pages 507-517.
Crossref
Crossref
Alexandra Kavushansky & Gal Richter-Levin. (2006) Effects of stress and corticosterone on activity and plasticity in the amygdala. Journal of Neuroscience Research 84:7, pages 1580-1587.
Crossref
Crossref
Jeffrey M. Witkin & William J.A. Eiler II. (2006) Antagonism of metabotropic glutamate group II receptors in the potential treatment of neurological and neuropsychiatric disorders. Drug Development Research 67:9, pages 757-769.
Crossref
Crossref
Anni-Maija Linden, Melvin Baez, Marcelle Bergeron & Darryle D. Schoepp. (2006) Effects of mGlu2 or mGlu3 receptor deletions on mGlu2/3 receptor agonist (LY354740)-induced brain c-Fos expression: Specific roles for mGlu2 in the amygdala and subcortical nuclei, and mGlu3 in the hippocampus. Neuropharmacology 51:2, pages 213-228.
Crossref
Crossref
Ruggero Galici, Carrie K. Jones, Kamondanai Hemstapat, Yi Nong, Nicholas G. Echemendia, Lilly C. Williams, Tomas de Paulis & P. Jeffrey Conn. (2006) Biphenyl-indanone A, a Positive Allosteric Modulator of the Metabotropic Glutamate Receptor Subtype 2, Has Antipsychotic- and Anxiolytic-Like Effects in Mice. Journal of Pharmacology and Experimental Therapeutics 318:1, pages 173-185.
Crossref
Crossref
Gabor Imre, Amber Salomons, Minke Jongsma, Dirk S. Fokkema, Johan A. Den Boer & Gert J. Ter Horst. (2006) Effects of the mGluR2/3 agonist LY379268 on ketamine-evoked behaviours and neurochemical changes in the dentate gyrus of the rat. Pharmacology Biochemistry and Behavior 84:3, pages 392-399.
Crossref
Crossref
Takao Yoshimizu, Toshiharu Shimazaki, Akie Ito & Shigeyuki Chaki. (2006) An mGluR2/3 antagonist, MGS0039, exerts antidepressant and anxiolytic effects in behavioral models in rats. Psychopharmacology 186:4, pages 587-593.
Crossref
Crossref
Pierre Blier, Rami Habib & Martine F Flament. (2016) Pharmacotherapies in the Management of Obsessive—Compulsive Disorder. The Canadian Journal of Psychiatry 51:7, pages 417-430.
Crossref
Crossref
Younglim Lee, Ronald S. Duman & Gerard J. Marek. (2006) The mGlu2/3 receptor agonist LY354740 suppresses immobilization stress-induced increase in rat prefrontal cortical BDNF mRNA expression. Neuroscience Letters 398:3, pages 328-332.
Crossref
Crossref
Leah J. Sartorius, Guhan Nagappan, Barbara K. Lipska, Bai Lu, Yoshitatsu Sei, Renee Ren-Patterson, Zhen Li, Daniel R. Weinberger & Paul J. Harrison. (2006) Alternative splicing of human metabotropic glutamate receptor 3. Journal of Neurochemistry 96:4, pages 1139-1148.
Crossref
Crossref
Varinder K. Aggarwal & Emma Grange. (2005) Asymmetric Sulfonium Ylide Mediated Cyclopropanation: Stereocontrolled Synthesis of (+)‐LY354740. Chemistry – A European Journal 12:2, pages 568-575.
Crossref
Crossref
Susana Mato, David Robbe, Nagore Puente, Pedro Grandes & Olivier J. Manzoni. (2005)
Presynaptic Homeostatic Plasticity Rescues Long-Term Depression after Chronic Δ
9
-Tetrahydrocannabinol Exposure
. The Journal of Neuroscience 25:50, pages 11619-11627.
Crossref
Crossref
Ruggero Galici, Nicholas G. Echemendia, Alice L. Rodriguez & P. Jeffrey Conn. (2005) A Selective Allosteric Potentiator of Metabotropic Glutamate (mGlu) 2 Receptors Has Effects Similar to an Orthosteric mGlu2/3 Receptor Agonist in Mouse Models Predictive of Antipsychotic Activity. Journal of Pharmacology and Experimental Therapeutics 315:3, pages 1181-1187.
Crossref
Crossref
Linda M. Rorick-Kehn, John C. Hart & David L. McKinzie. (2005) Pharmacological characterization of stress-induced hyperthermia in DBA/2 mice using metabotropic and ionotropic glutamate receptor ligands. Psychopharmacology 183:2, pages 226-240.
Crossref
Crossref
Veerle Bergink & Herman G. M. Westenberg. (2005) Metabotropic glutamate II receptor agonists in panic disorder: a double blind clinical trial with LY354740. International Clinical Psychopharmacology 20:6, pages 291-293.
Crossref
Crossref
Lee E. Schechter, Robert H. Ring, Chad E. Beyer, Zoë A. Hughes, Xavier Khawaja, Jessica E. Malberg & Sharon Rosenzweig-Lipson. (2005) Innovative approaches for the development of antidepressant drugs: Current and future strategies. NeuroRX 2:4, pages 590-611.
Crossref
Crossref
Andreas Ritzen, Jesper Mosolff Mathiesen & Christian Thomsen. (2005) Molecular Pharmacology and Therapeutic Prospects of Metabotropic Glutamate Receptor Allosteric Modulators. Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology 97:4, pages 202-213.
Crossref
Crossref
Céline Bonnefous, Jean-Michel Vernier, John H. Hutchinson, Michael F. Gardner, Merryl Cramer, Joyce K. James, Blake A. Rowe, Lorrie P. Daggett, Hervé Schaffhauser & Theodore M. Kamenecka. (2005) Biphenyl-indanones: Allosteric potentiators of the metabotropic glutamate subtype 2 receptor. Bioorganic & Medicinal Chemistry Letters 15:19, pages 4354-4358.
Crossref
Crossref
Thomas Steckler, Ana F.M. Oliveira, Chistophe Van Dyck, Hansfried Van Craenendonck, Ana M.A. Mateus, Xavier Langlois, Anne S.J. Lesage & Jos Prickaerts. (2005) Metabotropic glutamate receptor 1 blockade impairs acquisition and retention in a spatial Water maze task. Behavioural Brain Research 164:1, pages 52-60.
Crossref
Crossref
Peter R. BieckWilliam Z. Potter. (2005) BIOMARKERS IN PSYCHOTROPIC DRUG DEVELOPMENT: Integration of Data across Multiple Domains. Annual Review of Pharmacology and Toxicology 45:1, pages 227-246.
Crossref
Crossref
Joyce K. James, Masato Nakamura, Atsuro Nakazato, Kanyin E. Zhang, Merryl Cramer, Janice Brunner, Jacquelynn Cook & Weichao G. Chen. (2005) METABOLISM AND DISPOSITION OF A POTENT GROUP II METABOTROPIC GLUTAMATE RECEPTOR AGONIST, IN RATS, DOGS, AND MONKEYS. Drug Metabolism and Disposition 33:9, pages 1373-1381.
Crossref
Crossref
Steven P. Govek, Celine Bonnefous, John H. Hutchinson, Theodore Kamenecka, Jeffrey McQuiston, Richard Pracitto, Lucy X. Zhao, Michael F. Gardner, Joyce K. James, Lorrie P. Daggett, Blake A. Rowe, Hervé Schaffhauser, Linda J. Bristow, Una C. Campbell, Dana E. Rodriguez & Jean-Michel Vernier. (2005) Benzazoles as allosteric potentiators of metabotropic glutamate receptor 2 (mGluR2): Efficacy in an animal model for schizophrenia. Bioorganic & Medicinal Chemistry Letters 15:18, pages 4068-4072.
Crossref
Crossref
Pari Malherbe, J. Grayson Richards, Clemens Broger, Marie-Therese Zenner, Jurg Messer, Claudia Kratzeisen, Shigetada Nakanishi & Vincent Mutel. (2005) Opposite effects of Zn on the in vitro binding of [3H]LY354740 to recombinant and native metabotropic glutamate 2 and 3 receptors. Journal of Neurochemistry 94:1, pages 150-160.
Crossref
Crossref
Brad A Grueter & Danny G Winder. (2005) Group II and III Metabotropic Glutamate Receptors Suppress Excitatory Synaptic Transmission in the Dorsolateral Bed Nucleus of the Stria Terminalis. Neuropsychopharmacology 30:7, pages 1302-1311.
Crossref
Crossref
Grayson Richards, Jürg Messer, Pari Malherbe, Richard Pink, Manfred Brockhaus, Heinz Stadler, Jürgen Wichmann, Hervé Schaffhauser & Vincent Mutel. (2005)
Distribution and abundance of metabotropic glutamate receptor subtype 2 in rat brain revealed by [
3
H]LY354740 binding in vitro and quantitative radioautography: Correlation with the sites of synthesis, expression, and agonist stimulation of [
35
S]GTPγs binding
. Journal of Comparative Neurology 487:1, pages 15-27.
Crossref
Crossref
Daniel S. Lorrain, Christopher S. Baccei, Lucia D. Correa & Linda J. Bristow. (2005) Comparison of the effects of diazepam, the CRF1 antagonist CP-154,526 and the group II mGlu receptor agonist LY379268 on stress-evoked extracellular norepinephrine levels. Neuropharmacology 48:7, pages 927-935.
Crossref
Crossref
Rowena V. Cube, Jean-Michel Vernier, John H. Hutchinson, Michael F. Gardner, Joyce K. James, Blake A. Rowe, Herve Schaffhauser, Lorrie Daggett & Anthony B. Pinkerton. (2005) 3-(2-Ethoxy-4-{4-[3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxy]butoxy}phenyl)propanoic acid: a brain penetrant allosteric potentiator at the metabotropic glutamate receptor 2 (mGluR2). Bioorganic & Medicinal Chemistry Letters 15:9, pages 2389-2393.
Crossref
Crossref
Jean-Philippe Pin. (2005) Moduler l’action du glutamate dans le cerveau: de nouvelles pistes ouvertes grâce aux récepteurs métabotropiquesModulating the action of glutamate in the brain: new possibilities opened up by the metabotropic receptors. PSN 3:3, pages 132-142.
Crossref
Crossref
Houman Homayoun, Mark E. Jackson & Bita Moghaddam. (2005) Activation of Metabotropic Glutamate 2/3 Receptors Reverses the Effects of NMDA Receptor Hypofunction on Prefrontal Cortex Unit Activity in Awake Rats. Journal of Neurophysiology 93:4, pages 1989-2001.
Crossref
Crossref
James N. C. Kew & John A. Kemp. (2005) Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology 179:1, pages 4-29.
Crossref
Crossref
Jason P. Schroeder, David H. Overstreet & Clyde W. Hodge. (2005) The mGluR5 antagonist MPEP decreases operant ethanol self-administration during maintenance and after repeated alcohol deprivations in alcohol-preferring (P) rats. Psychopharmacology 179:1, pages 262-270.
Crossref
Crossref
Simona Spinelli, Theresa Ballard, Silvia Gatti-McArthur, Grayson J. Richards, Martin Kapps, Thomas Woltering, Jurgen Wichmann, Heinz Stadler, Joram Feldon & Christopher R. Pryce. (2005) Effects of the mGluR2/3 agonist LY354740 on computerized tasks of attention and working memory in marmoset monkeys. Psychopharmacology 179:1, pages 292-302.
Crossref
Crossref
Michael P. Johnson, David Barda, Thomas C. Britton, Renee Emkey, William J. Hornback, G. Erik Jagdmann, David L. McKinzie, Eric S. Nisenbaum, Joseph P. Tizzano & Darryle D. Schoepp. (2005) Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s). Psychopharmacology 179:1, pages 271-283.
Crossref
Crossref
A.-M. Linden, H. Shannon, M. Baez, J. L. Yu, A. Koester & D. D. Schoepp. (2004) Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice. Psychopharmacology 179:1, pages 284-291.
Crossref
Crossref
John H. Krystal, Walid Abi-Saab, Edward Perry, D. Cyril D’Souza, Nianjin Liu, Ralitza Gueorguieva, Lisa McDougall, Tracy Hunsberger, Aysenil Belger, Louise Levine & Alan Breier. (2004) Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects. Psychopharmacology 179:1, pages 303-309.
Crossref
Crossref
Anthony B. Pinkerton, Rowena V. Cube, John H. Hutchinson, Joyce K. James, Michael F. Gardner, Blake A. Rowe, Hervé Schaffhauser, Dana E. Rodriguez, Una C. Campbell, Lorrie P. Daggett & Jean-Michel Vernier. (2005) Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 3: Identification and biological activity of indanone containing mGlu2 receptor potentiators. Bioorganic & Medicinal Chemistry Letters 15:6, pages 1565-1571.
Crossref
Crossref
Chad J. Swanson, Mark Bures, Michael P. Johnson, Anni-Maija Linden, James A. Monn & Darryle D. Schoepp. (2005) Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nature Reviews Drug Discovery 4:2, pages 131-144.
Crossref
Crossref
A.-M. Linden, M. Bergeron & D.D. Schoepp. (2005) Comparison of c-Fos induction in the brain by the mGlu2/3 receptor antagonist LY341495 and agonist LY354740: Evidence for widespread endogenous tone at brain mGlu2/3 receptors in vivo. Neuropharmacology 49, pages 120-134.
Crossref
Crossref
James N.C. Kew. (2004) Positive and negative allosteric modulation of metabotropic glutamate receptors: emerging therapeutic potential. Pharmacology & Therapeutics 104:3, pages 233-244.
Crossref
Crossref
Anthony B. Pinkerton, Rowena V. Cube, John H. Hutchinson, Joyce K. James, Michael F. Gardner, Hervé Schaffhauser, Blake A. Rowe, Lorrie P. Daggett & Jean-Michel Vernier. (2004) Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 2: 4-Thiopyridyl acetophenones as non-tetrazole containing mGlu2 receptor potentiators. Bioorganic & Medicinal Chemistry Letters 14:23, pages 5867-5872.
Crossref
Crossref
D C Javitt. (2004) Glutamate as a therapeutic target in psychiatric disorders. Molecular Psychiatry 9:11, pages 984-997.
Crossref
Crossref
Anthony B. Pinkerton, Rowena V. Cube, John H. Hutchinson, Blake A. Rowe, Hervé Schaffhauser, Xiumin Zhao, Lorrie P. Daggett & Jean-Michel Vernier. (2004) Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 1: Identification and synthesis of phenyl-tetrazolyl acetophenones. Bioorganic & Medicinal Chemistry Letters 14:21, pages 5329-5332.
Crossref
Crossref
Trevor R. Norman. (2004) Fifth World Congress on Stress, London, 18–19 June 2004. Stress and Health 20:4, pages 173-174.
Crossref
Crossref
Anthony B. Pinkerton, Jean-Michel Vernier, Hervé Schaffhauser, Blake A. Rowe, Una C. Campbell, Dana E. Rodriguez, Daniel S. Lorrain, Christopher S. Baccei, Lorrie P. Daggett & Linda J. Bristow. (2004) Phenyl-tetrazolyl Acetophenones: Discovery of Positive Allosteric Potentiatiors for the Metabotropic Glutamate 2 Receptor. Journal of Medicinal Chemistry 47:18, pages 4595-4599.
Crossref
Crossref
David A. Barda, Zhao-Qing Wang, Thomas C. Britton, Steven S. Henry, G.Erik Jagdmann, Darrell S. Coleman, Michael P. Johnson, Sherri L. Andis & Darryle D. Schoepp. (2004) SAR study of a subtype selective allosteric potentiator of metabotropic glutamate 2 receptor, N-(4-phenoxyphenyl)-N-(3-pyridinylmethyl)ethanesulfonamide. Bioorganic & Medicinal Chemistry Letters 14:12, pages 3099-3102.
Crossref
Crossref
A-M Linden, S J Greene, M Bergeron & D D Schoepp. (2003) Anxiolytic Activity of the MGLU2/3 Receptor Agonist LY354740 on the Elevated Plus Maze is Associated with the Suppression of Stress-Induced c-Fos in the Hippocampus and Increases in c-Fos Induction in Several Other Stress-Sensitive Brain Regions. Neuropsychopharmacology 29:3, pages 502-513.
Crossref
Crossref
Omer Bonne, Christian Grillon, Meena Vythilingam, Alexander Neumeister & Dennis S Charney. (2004) Adaptive and maladaptive psychobiological responses to severe psychological stress: implications for the discovery of novel pharmacotherapy. Neuroscience & Biobehavioral Reviews 28:1, pages 65-94.
Crossref
Crossref
Aikaterini Makatsori, Roman Duncko, Fedor Moncek, Ingrid Loder, Stanislav Katina & Daniela Jezova. (2004) Modulation of Neuroendocrine Response and Non-Verbal Behavior during Psychosocial Stress in Healthy Volunteers by the Glutamate Release-Inhibiting Drug Lamotrigine. Neuroendocrinology 79:1, pages 34-42.
Crossref
Crossref
Antonio de Pádua Carobrez. (2003) Transmissão pelo glutamato como alvo molecular na ansiedade. Revista Brasileira de Psiquiatria 25:suppl 2, pages 52-58.
Crossref
Crossref
CHAD J. SWANSON & DARRYLE D. SCHOEPP. (2003) A Role for Noradrenergic Transmission in the Actions of Phencyclidine and the Antipsychotic and Antistress Effects of mGlu2/3 Receptor Agonists. Annals of the New York Academy of Sciences 1003:1, pages 309-317.
Crossref
Crossref